NASDAQ:CDT CDT Equity (CDT) Stock Price, News & Analysis $0.53 -0.05 (-8.40%) As of 12:55 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About CDT Equity Stock (NASDAQ:CDT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CDT Equity alerts:Sign Up Key Stats Today's Range$0.53▼$0.5850-Day Range$0.58▼$3.4652-Week Range$0.53▼$586.00Volume319,454 shsAverage Volume3.55 million shsMarket Capitalization$2.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited. Read More CDT Equity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreCDT MarketRank™: CDT Equity scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCDT Equity has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCDT Equity has only been the subject of 1 research reports in the past 90 days.Read more about CDT Equity's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.91% of the float of CDT Equity has been sold short.Short Interest Ratio / Days to CoverCDT Equity has a short interest ratio ("days to cover") of 0.11, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CDT Equity has recently decreased by 26.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCDT Equity does not currently pay a dividend.Dividend GrowthCDT Equity does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.88 News SentimentCDT Equity has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for CDT Equity this week, compared to 2 articles on an average week.Search Interest4 people have searched for CDT on MarketBeat in the last 30 days. MarketBeat Follows1 people have added CDT Equity to their MarketBeat watchlist in the last 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CDT Equity insiders have not sold or bought any company stock.Percentage Held by Insiders10.78% of the stock of CDT Equity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions3.29% of the stock of CDT Equity is held by institutions.Read more about CDT Equity's insider trading history. Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CDT Equity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDT Stock News HeadlinesCDT Equity (NASDAQ:CDT) Stock Rating Lowered by Wall Street ZenJune 27 at 1:26 AM | americanbankingnews.comCDT Equity Inc. Notes Sarborg Limited’s Expansion of Signature Intelligence Platform into Quantum-Assisted Coformer SelectionJune 26, 2026 | quiverquant.comQThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes could be the next monster IPO on Wall Street. This company is growing 23 times faster than Nvidia. The Atlantic called it 'the fastest-growing business in the history of capitalism.' It has nothing to do with robots, self-driving cars, or rockets.June 30 at 1:00 AM | Brownstone Research (Ad)CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form DevelopmentJune 26, 2026 | globenewswire.comCDT Equity Stock Gets A Boost On SarborgQ Development NewsJune 18, 2026 | benzinga.comCDT jumps after Sarborg funding update spotlights value of CDT’s stakeJune 18, 2026 | quiverquant.comQCDT Notes Strategic Investment into Sarborg and Expansion into Quantum ComputingJune 18, 2026 | globenewswire.comCDT Equity Simplifies Capital Structure With Single Lender FacilityJune 16, 2026 | tipranks.comSee More Headlines CDT Stock Analysis - Frequently Asked Questions How have CDT shares performed this year? CDT Equity's stock was trading at $32.00 at the start of the year. Since then, CDT shares have decreased by 98.3% and is now trading at $0.5540. How were CDT Equity's earnings last quarter? CDT Equity Inc. (NASDAQ:CDT) released its quarterly earnings data on Thursday, August, 14th. The company reported ($1,092.00) EPS for the quarter. When did CDT Equity's stock split? CDT Equity's stock reverse split on the morning of Friday, March 27th 2026.The 1-25 reverse split was announced on Wednesday, March 25th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 26th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CDT Equity? Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CDT Equity own? Based on aggregate information from My MarketBeat watchlists, some other companies that CDT Equity investors own include BIOLASE (BIOL), Dare Bioscience (DARE), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Canoo (GOEV) and Jiuzi (JZXN). Company Calendar Last Earnings8/14/2025Today6/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (24m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 CDT's financial health is in the Red zone, according to TradeSmith. CDT has been in this zone for over 24 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CDT Previous SymbolNASDAQ:CDT CIK1896212 Webwww.conduitpharma.com Phone760-471-8536FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)($66,338.5469) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.22 million Net MarginsN/A Pretax MarginN/A Return on Equity-4,263.33% Return on Assets-529.91% Debt Debt-to-Equity RatioN/A Current Ratio0.34 Quick Ratio0.34 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($77.82) per share Price / Book-0.01Miscellaneous Outstanding Shares4,860,000Free Float4,334,000Market Cap$2.59 million OptionableNot Optionable Beta1.44 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:CDT) was last updated on 6/30/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredThe pre-flight check for options tradersPilots never skip their pre-flight checklist - and neither should options traders. The Smart Trade Options Che...Profits Run | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored[Free Report] The 11-Hour Options Guide for Beginners - trade and ticker includedTired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CDT Equity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CDT Equity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
